PP381 Sintilimab Combined with Anlotinib in Metastatic NSCLC with Uncommon EGFR Mutations: A Prospective, Single-Arm, Phase II TrialKaiyan Chen,Yun FanESMO Open(2023)引用 0|浏览7AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要